Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry

Pierpaolo Di Micco,1 Manuel Monreal2 1Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy; 2Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, SpainCo...

Full description

Bibliographic Details
Main Authors:	Di Micco P, Monreal M
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-01-01
Series:	Journal of Blood Medicine
Subjects:	thrombocytopenia venous thromboembolism bleeding bleeding risk
Online Access:	https://www.dovepress.com/platelet-count-and-bleeding-in-patients-receiving-anticoagulant-therap-peer-reviewed-article-JBM

Similar Items

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)

Platelet count and risk of major bleeding in venous thromboembolism
by: Håkon S. Johnsen, et al.
Published: (2021-05-01)

Bleeding and venous thromboembolism events in cancer patients taking direct oral anticoagulants vs. low molecular weight heparin
by: Frank A. Lattuca, et al.
Published: (2023-03-01)

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
by: Alvaro Alonso, et al.
Published: (2021-09-01)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
by: Faizan Khan, et al.
Published: (2019-10-01)

Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients
by: Veronica Abate, et al.
Published: (2023-07-01)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
by: Viktoria Muster, et al.
Published: (2021-06-01)

A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism
by: Gabrielle Sarlon-Bartoli, et al.
Published: (2023-12-01)

Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01)

Risk factors for Venous thromboembolism and duration of anticoagulation therapy
by: Antonijević Nebojša M., et al.
Published: (2013-01-01)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
by: Géraldine Poénou, et al.
Published: (2023-08-01)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
by: Yong-Jian Zhu, et al.
Published: (2021-05-01)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
by: Kochawan Boonyawat, et al.
Published: (2021-02-01)

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry
by: Paolo Prandoni, et al.
Published: (2022-05-01)

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
by: Yanina Balabanova, et al.
Published: (2022-02-01)

Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry
by: Carmine Siniscalchi, et al.
Published: (2020-07-01)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
by: Frederikus A. Klok, et al.
Published: (2019-07-01)

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
by: Hass Bastian, et al.
Published: (2012-12-01)

Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19
by: Scott C. Woller, et al.
Published: (2022-07-01)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
by: Håkon S. Johnsen, et al.
Published: (2019-01-01)

Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study
by: Kristina Vrotniakaite-Bajerciene, et al.
Published: (2023-09-01)

Clinical characteristics of italian patients with venous thromboembolism enrolled in the RIETE Registry
by: Pierpaolo Di Micco, et al.
Published: (2012-01-01)

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-08-01)

Risk stratification scores for major bleeding in patients with venous thromboembolism
by: Francisco Galeano-Valle, et al.
Published: (2021-01-01)

VTE Registry: What Can Be Learned from RIETE?
by: Inna Tzoran, et al.
Published: (2014-10-01)

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
by: Antoni Riera-Mestre, et al.
Published: (2019-08-01)

OPTIONS FOR USE OF APPROPRIATE ANTICOAGULANT THERAPY IN PATIENTS WITH THERMAL INJURY WITH A HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS DEVELOPMENT ASSOCIATED WITH RECURRENT INTESTINAL BLEEDING
by: V. S. Borisov, et al.
Published: (2016-02-01)

Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-02-01)

Efficacy of the bleeding risk scoring system for optimal prophylactic anticoagulation therapy of venous thromboembolism in trauma patients: a single-center, retrospective, observational cohort study
by: Atsushi Tomizawa, et al.
Published: (2023-12-01)

Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study
by: Frederik Pagh Bredahl Kristensen, et al.
Published: (2024-01-01)

A Comparison among Nonvitamin K Antagonist Oral Anticoagulants in Asian Patients with Venous Thromboembolism: A Multi-Institutional Study
by: Ming-Lung Tsai, et al.
Published: (2022-12-01)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
by: Alexander Cohen, et al.
Published: (2021-01-01)

Venous Thromboembolism Prophylaxis and The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Score in Medical Illness Patients
by: Dania Artriana Riswandi, et al.
Published: (2020-04-01)

Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study
by: Jennifer Howlett, et al.
Published: (2020-05-01)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
by: Giuseppe Pompilio, et al.
Published: (2020-04-01)

Thromboembolism and bleeding in systemic amyloidosis: a review
by: Martin Nicol, et al.
Published: (2022-02-01)

Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography
by: Jaroslaw Zalewski, et al.
Published: (2020-06-01)

Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials
by: Guowei Li, et al.
Published: (2020-06-01)

Risk factors for bleeding in patients receiving fondaparinux after colorectal cancer surgery
by: Jongsung Pak, et al.
Published: (2017-10-01)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
by: Loredana Bury, et al.
Published: (2021-02-01)